Glioma: all 1,425 studies
Page 13 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Study of Tissue Samples From Patients With Glioma or Other Brain TumorsCompletedNCT00967200
- ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsCompletedNCT00946335Phase 1
- Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade GliomasCompletedNCT00942760
- Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/SpectroscopyCompletedNCT00939315
- Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00929903Phase 1
- Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma MultiformeCompletedNCT00919737Phase 1/2
- Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)CompletedNCT00901849Phase 1
- DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem GliomaCompletedNCT00899834
- Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant GliomaCompletedNCT00897611Not applicable
- Study of Stored Tumor Samples in Young Patients With Brain TumorsTerminatedNCT00897286
- Tumor Tissue, Blood Samples, and Family History in Predicting Tumor Development and Response to Treatment in Young Patients With Low-Grade GliomaStatus unknownNCT00891722
- A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine GliomasCompletedNCT00890786Early Phase 1
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade GliomaActive, not recruitingNCT00887146Phase 3
- An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade GliomaTerminatedNCT00880061Phase 1
- HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II GliomasCompletedNCT00874861Early Phase 1
- ADV-TK Improves Outcome of Recurrent High-Grade GliomaCompletedNCT00870181Phase 2
- Study of LBH589 (Panobinostat) to Treat Malignant Brain TumorsTerminatedNCT00848523Phase 2
- The Effects of Adding a Home Exercise Program to a Clinical Physical Therapy Program on Cancer-Related FatigueCompletedNCT00840554Not applicable
- Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade GliomaTerminatedNCT00826930Phase 1
- Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant GliomasCompletedNCT00822887Phase 1
- Coping With High Grade GliomaTerminatedNCT00815152Not applicable
- Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 ComponentsStatus unknownNCT00813787
- DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant GliomasCompletedNCT00805376Phase 1
- Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-AstrocytomasCompletedNCT00795457Early Phase 1
- Borderzone SamplingCompletedNCT00780819Not applicable
- Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant GliomasCompletedNCT00751270Phase 1
- Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant GliomaWithdrawnNCT00734864Phase 1
- Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant GliomaCompletedNCT00730613Phase 1
- Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)CompletedNCT00705198
- A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant GliomasCompletedNCT00704080Phase 1
- Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent TumorCompletedNCT00694330Phase 1
- Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant GliomaCompletedNCT00687765Phase 1/2
- A Study of 131I-TM601 in Adults With Recurrent Malignant GliomaStatus unknownNCT00683761Phase 1/2
- Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase ITerminatedNCT00671801Phase 1
- A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade GliomaStatus unknownNCT00660621Phase 2
- A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade GliomaStatus unknownNCT00660283Phase 2
- Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaCompletedNCT00650923Phase 1
- Positron Emission Tomography-Computed Tomography (PET-CT) High-grade GliomaTerminatedNCT00643591
- Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorCompletedNCT00638898Phase 1
- A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsCompletedNCT00634231Phase 1
- PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?CompletedNCT00628940Phase 1
- Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by SurgeryCompletedNCT00626015Phase 1
- Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)CompletedNCT00624728Phase 1/2
- Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + TemozolomideCompletedNCT00616005Phase 2
- Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant GliomasCompletedNCT00613223Phase 1
- Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant GliomaCompletedNCT00613093Phase 2
- Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant GliomaCompletedNCT00613054Phase 1
- PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant GliomasCompletedNCT00612651Phase 1
- Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic GliomasCompletedNCT00612638Phase 1
- Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00612001Phase 1
- Ph I Oral Topotecan and Temozolomide for Patients With Malignant GliomasCompletedNCT00610571Phase 1
- Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine GliomaCompletedNCT00600054Phase 2
- Bevacizumab in the Radiation Treatment of Recurrent Malignant GliomaCompletedNCT00595322Not applicable
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant GliomaStatus unknownNCT00591058Phase 1
- A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade GliomasCompletedNCT00589706Phase 2
- Immunotherapy for Patients With Brain Stem Glioma and GlioblastomaCompletedNCT00576641Phase 1
- Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma PatientsCompletedNCT00576446Phase 1
- Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)Status unknownNCT00575796Phase 2
- Nimotuzumab in Children With HGGCompletedNCT00561873
- Nimotuzumab in Children With Intrinsic Pontine GliomaCompletedNCT00561691
- Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBMTerminatedNCT00548938Phase 2
- The Safety and Efficacy of DCA for the Treatment of Brain CancerCompletedNCT00540176Phase 2
- A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant GliomaCompletedNCT00539344Phase 1
- Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant GliomasCompletedNCT00528684Phase 1
- A Safety Study of RTA 744 in Patients With Recurrent High-Grade GliomasCompletedNCT00526812Phase 1
- Enzastaurin and Temozolomide in Treating Patients With Primary GliomasStatus unknownNCT00516607Phase 1
- VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant GliomaTerminatedNCT00516282Phase 1
- Temozolomide and Radiation Therapy in Treating Young Patients With Pontine GliomaStatus unknownNCT00514397Phase 2
- Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00509431Phase 1
- Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem GliomaCompletedNCT00472017Phase 1
- Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapyTerminatedNCT00471653
- Minimized Time to Beam in Patients With High Grade GliomasWithdrawnNCT00469534Not applicable
- Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant GlioblastomasCompletedNCT00463073Phase 2
- Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma MultiformeCompletedNCT00458601Phase 2
- Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With EpilepsyStatus unknownNCT00454935
- Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant GliomaTerminatedNCT00430079Not applicable
- A Phase II Study to Treat Advanced Malignant GliomaCompletedNCT00427440Phase 2
- Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem GliomaCompletedNCT00418327Phase 1
- Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of GliomaCompletedNCT00409214Phase 2
- Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaCompletedNCT00401024Phase 1
- A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic GliomaTerminatedNCT00389090Phase 2
- Short Course of Radiation for Gliomas in Elderly PatientsCompletedNCT00386919Phase 2
- Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant GliomaWithdrawnNCT00378235Phase 1/2
- Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaCompletedNCT00363272Phase 1
- Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem GliomaStatus unknownNCT00360854Phase 1
- Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade GliomaCompletedNCT00357253Phase 1
- Imatinib Mesylate and Temozolomide in Treating Patients With Malignant GliomaCompletedNCT00354068Phase 1
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant GliomaCompletedNCT00352521Phase 2
- Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT00352495Phase 1
- ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant GliomaCompletedNCT00352313Phase 1/2
- A Family Study of Adults With GliomaCompletedNCT00339352
- A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)CompletedNCT00337883Phase 2
- Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging TechnologyStatus unknownNCT00330109Not applicable
- AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS TumorsCompletedNCT00326664Phase 1
- Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain TumorsCompletedNCT00303849Phase 1/2
- Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation NecrosisCompletedNCT00285324
- Genetic Epidemiology of Adult Onset GliomaCompletedNCT00283569
- High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant GliomaCompletedNCT00283556Phase 1/2
- Radiation With Concomitant and Then Sequential Temozolomide in Malignant GliomaStatus unknownNCT00283543Phase 2
- Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed GliomasStatus unknownNCT00278278Phase 3